ESR1 and breast cancer: High levels of EMT markers (ZEB1/ZEB2) and low levels of the miR-200 family (miR-200a/-b/-c) resulted in the resistance of estrogen receptor (ER)-positive breast cancer cells to tamoxifen [91].